Term
Acetaminophen
(Tylenol)
NCCEP Protocol:
|
|
Definition
7-Pain Control-Adult
46-Pain Control-Pediatric
72-Fever |
|
|
Term
Acetaminophen
(Tylenol)
Indications/Contraindications: |
|
Definition
Indicated for pain and fever control
Avoid in patients with severe liver
disease |
|
|
Term
Acetaminophen
(Tylenol)
Adult Dosing |
|
Definition
|
|
Term
Acetaminophen
(Tylenol)
Pediatric Dosing |
|
Definition
See Color Coded List
15 mg/kg po |
|
|
Term
Adenosine
(Adenocard)
NCCEP Protocol: |
|
Definition
16-Adult Tachycardia Narrow
Complex
17-Adult Tachycardia Wide
Complex
52-Pediatric Tachycardia |
|
|
Term
Adenosine
(Adenocard)
Indications/Contraindications: |
|
Definition
Specifically for treatment or
diagnosis of Supraventricular
Tachycardia |
|
|
Term
| Adenosine(Adenocard) Adult Dose |
|
Definition
6 mg IV push over 1-3 seconds. If
no effect after 1-2 minutes,
Repeat with 12 mg IV push over 1-
3 seconds.
Repeat once if necessary
(use stopcock and 20 ml Normal
Saline flush with each dose) |
|
|
Term
| Adenosine(Adenocard) Pediatric Dose |
|
Definition
0.1 mg/kg IV (Max 6 mg) push
over 1-3 seconds. If no effect
after 1-2 minutes,
Repeat with 0.2 mg/kg IV (Max
12 mg) push over 1-3 seconds.
Repeat once if necessary
(use stopcock and Normal Saline
flush with each dose) |
|
|
Term
Albuterol
Beta-Agonist
NCCEP Protocol: |
|
Definition
24-Allergic Reaction Anaphylaxis
26-COPD Asthma
56-Pediatic Allergic Reaction
61-Pediatric Respiratory Distress |
|
|
Term
Albuterol
Beta-Agonist
Indications/Contraindications: |
|
Definition
Beta-Agonist nebulized treatment
for use in respiratory distress with
bronchospasm |
|
|
Term
Albuterol
Beta-Agonist
Adult Dose |
|
Definition
2.5-5.0 mg (3cc) in nebulizer
continuously x 3 doses. See local
protocol for relative
contraindications and/or indications
to contact medical control for use
of this drug. |
|
|
Term
Albuterol
Beta-Agonist
Pediatric Dose |
|
Definition
See Color Coded List
2.5mg (3cc) in nebulizer
continuously x 3 doses. See local
protocol for relative
contraindications and/or
indications to contact medical
control for use of this drug. |
|
|
Term
Amiodarone
(Cordarone)
NCCEP Protocol: |
|
Definition
17-Adult Tachycardia Wide
Complex
18-VF Pulseless VT
52-Pediatric Tachycardia
53-Pediatric VF Pulseless VT
54-Pediatric Post Resuscitation |
|
|
Term
Amiodarone
(Cordarone)
Indications/Contraindications: |
|
Definition
Antiarrhythmic used mainly in wide
complex tachycardia and
ventricular fibrillation.
Avoid in patients with heart block or
profound bradycardia.
Contraindicated in patients with
iodine hypersensitivity |
|
|
Term
Amiodarone
(Cordarone)
Adult Dose
|
|
Definition
V-fib / pulseless V-tach
300 mg IV push
Repeat dose of 150 mg IV push
for recurrent episodes
V-tach with a pulse
150 mg in 100cc D5W over 10 min |
|
|
Term
Amiodarone
(Cordarone)
Pediatric Dose |
|
Definition
V-fib / pulseless V-tach
5 mg/kg IV push over 5 minutes
May repeat up to 15mg/kg IV
V-tach with a pulse
5 mg/kg IV push over 5 minutes May repeat up to 15mg/kg IV
Avoid in Length Tape Color Pink |
|
|
Term
|
Definition
7-Pain Control Adult
14-Chest Pain and STEMI |
|
|
Term
Aspirin
Indications/Contraindications |
|
Definition
An antiplatelet drug for use in
cardiac chest pain |
|
|
Term
|
Definition
81 mg chewable (baby) Aspirin
Give 4 tablets to equal usual adult
dose. |
|
|
Term
|
Definition
12-Bradycardia Pulse Present
49-Pediatric Bradycardia
84-WMD Nerve Agent |
|
|
Term
Atropine
Indications/Contraindications: |
|
Definition
Anticholinergic drug used in
bradycardias.
(For Endotracheal Tube use of this
drug, double the dose)
In Organophosphate toxicity, large
doses may be required (>10 mg) |
|
|
Term
Atropine
Adult Dose Bradycardia |
|
Definition
0.5 - 1.0 mg IV every 3 – 5 minutes
up to 3 mg.
(If endotracheal -- max 6 mg) |
|
|
Term
Atropine
Adult Dose Organophosphates |
|
Definition
1-2 mg IM or IV otherwise as per
medical control |
|
|
Term
Atropine
Pediatric Dose Bradycardia |
|
Definition
0.02 mg/kg IV, IO (Max 0.5 mg
per dose, Max total dose 1mg IV)
(Min 0.1 mg) per dose
May repeat in 3 - 5 minutes |
|
|
Term
Atropine
Pediatric Dose Organophosphates |
|
Definition
0.05 mg/kg IV or IO otherwise as
per medical control |
|
|
Term
Atropine and
Pralidoxime Auto-
Injector
Nerve Agent Kit
NCCEP Protocol: |
|
Definition
|
|
Term
Atropine and
Pralidoxime Auto-
Injector
Nerve Agent Kit
Indications/Contraindications: |
|
Definition
Antidote for Nerve Agents or
Organophosphate Overdose |
|
|
Term
Atropine and
Pralidoxime Auto-
Injector
Nerve Agent Kit
Adult and Pediatric Dose |
|
Definition
One auto-injector then per medical
control |
|
|
Term
Calcium Chloride
NCCEP Protocol: |
|
Definition
28-Dialysis Renal Failure
31-Overdose Toxic Ingestion
60-Ped OD Toxic Ingestion
83-Marine Envenomations
88-Crush Syndrome |
|
|
Term
Calcium Chloride
Indications/Contraindications: |
|
Definition
| Indicated for severe hyperkalemia |
|
|
Term
Calcium Chloride
Adult Dose |
|
Definition
1 gm IV / IO
Avoid use if pt is taking digoxin |
|
|
Term
Calcium Chloride
Pediatric Dose |
|
Definition
See Color Coded List
20 mg/kg IV or IO slowly |
|
|
Term
Dextrose 10%, 25%,
50%
Glucose solutions
NCCEP Protocol: |
|
Definition
|
|
Term
Dextrose 10%, 25%,
50%
Glucose solutions
Indications/Contraindications: |
|
Definition
Use in altered mental status or
hypoglycemic states |
|
|
Term
Dextrose 10%, 25%,
50%
Glucose solutions
Adult and Pediatric Dose |
|
Definition
See local protocol for concentration
and dosing |
|
|
Term
Diazepam
(Valium)
Benzodiazepene
NCCEP Protocol: |
|
Definition
32-Seizure
39-Obstetrical Emergency
62-Pediatric Seizure |
|
|
Term
Diazepam
(Valium)
Benzodiazepene
Indications/Contraindications: |
|
Definition
Seizure control
Mild Sedation |
|
|
Term
Diazepam
(Valium)
Benzodiazepene
Adult Dose |
|
Definition
4 mg IV / IO initially then 2 mg IV /
IO every 3 - 5 minutes up to 10 mg
max unless med control dictates
Do not administer IM. The drug is
not absorbed.
10 mg Rectally if unable to obtain
an IV. |
|
|
Term
Diazepam
(Valium)
Benzodiazepene
Pediatric Dose |
|
Definition
See Color Coded List
0.1 - 0.3 mg/kg IV/IO
(Max dose 4 mg IV, IO)
0.5 mg/kg rectally (Dia-Stat)
(Max dose 10 mg rectally)
Repeat as directed by local
protocol |
|
|
Term
Diltiazem
(Cardizem)
Calcium Channel
Blocker
NCCEP Protocol: |
|
Definition
16-Adult Tachycardia Narrow
Complex |
|
|
Term
Diltiazem
(Cardizem)
Calcium Channel
Blocker
Indications/Contraindications:
|
|
Definition
Calcium channel blocker used to
treat narrow complex SVT
Contraindicated in patients with
heart block, ventricular
tachycardia, and/or acute MI |
|
|
Term
Diltiazem
(Cardizem)
Calcium Channel
Blocker
Adult Only Dose |
|
Definition
|
|
Term
Diltiazem
(Cardizem)
Calcium Channel
Blocker
Drip |
|
Definition
| 100 mg in 250 cc run with the lidocaine clock |
|
|
Term
Diphenhydramine
(Benadryl)
NCCEP Protocol: |
|
Definition
24-Allergic Reaction Anaphylaxis
56-Pediatic Allergic Reaction |
|
|
Term
Diphenhydramine
(Benadryl)
Indications/Contraindications: |
|
Definition
Antihistamine for control of allergic
reactions |
|
|
Term
Diphenhydramine
(Benadryl)
adult dose |
|
Definition
|
|
Term
Diphenhydramine
(Benadryl)
Pediatric Dose |
|
Definition
See Color Coded List
1 mg/kg IV/IO/IM/PO
Do not give in infants < 3 mo |
|
|
Term
|
Definition
|
|
Term
Dopamine
Indications/Contraindications: |
|
Definition
A vasopressor used in shock or
hypotensive states |
|
|
Term
|
Definition
2 - 20 micrograms/kg/min IV or IO,
titrate to BP systolic of 90 mmHg |
|
|
Term
|
Definition
See Color Coded List
2 - 20 micrograms/kg/min IV or
IO, titrate to BP systolic
appropriate for age |
|
|
Term
Epinephrine 1:1,000
NCCEP Protocol: |
|
Definition
|
|
Term
Epinephrine 1:1,000
Indications/Contraindications: |
|
Definition
Vasopressor used in allergic
reactions or anaphylaxis |
|
|
Term
Epinephrine 1:1,000
Adult Dosing |
|
Definition
0.3 mg IM
See local protocol for relative
contraindications and/or indications
to contact medical control for use
of this drug. |
|
|
Term
Epinephrine 1:1,000
Adult Neb Epi |
|
Definition
1 mg mixed with 2 ml of Normal
Saline |
|
|
Term
Epinephrine 1:1,000
Pediatric Dosing |
|
Definition
See Color Coded List
0.01 mg/kg IM
(Max dose 0.3 mg) |
|
|
Term
Epinephrine 1:1,000
Pediatric Neb Epi |
|
Definition
1 mg mixed with 2 ml of Normal
Saline |
|
|
Term
Epinephrine 1:10,000
NCCEP Protocol: |
|
Definition
|
|
Term
Epinephrine 1:10,000
Indications/Contraindications: |
|
Definition
Vasopressor used in cardiac
arrest. |
|
|
Term
Epinephrine 1:10,000
Adult Dosing |
|
Definition
1.0 mg IV / IO
Repeat every 3 - 5 minutes until
observe response
(May be given by Endotracheal
tube in double the IV dose) |
|
|
Term
Epinephrine 1:10,000
Pediatric Dosing |
|
Definition
See Color Coded List
0.01 mg/kg IV or IO
(Max dose 1 mg)
Repeat every 3 - 5 minutes per
protocol
(May be given by Endotracheal
tube in double the IV dose) |
|
|
Term
Etomidate
(Amidate)
NCCEP Protocol: |
|
Definition
4-Airway Rapid Sequence
Intubation
20-Induced Hypothermia |
|
|
Term
Etomidate
(Amidate)
Indications/Contraindications: |
|
Definition
Sedative used in Drug Assisted
Intubation |
|
|
Term
Etomidate
(Amidate)
Adult only Dose
No Pediatric Use |
|
Definition
0.3 mg/kg IV / IO
Usual adult dose = 20 mg |
|
|
Term
Fentanyl
(Sublimaze)
Narcotic Analgesic
NCCEP Protocol: |
|
Definition
|
|
Term
Fentanyl
(Sublimaze)
Narcotic Analgesic
Indications/Contraindications: |
|
Definition
Narcotic pain relief
Possible beneficial effect in
pulmonary edema
Avoid use if BP < 110 |
|
|
Term
Fentanyl
(Sublimaze)
Narcotic Analgesic
Adult Dose |
|
Definition
50-75 mcg IM/IV/IO bolus then 25
mcg IM/IV/IO every 20 minutes
until a maximum of 200 mcg or
clinical improvement |
|
|
Term
Fentanyl
(Sublimaze)
Narcotic Analgesic
Pediatric Dose |
|
Definition
See Color Coded List
1 mcg/kg IM/IN/IV/IO
May repeat 0.5 mcg/kg every 5
minutes
Maximum dose 2 mcg/kg |
|
|
Term
Furosemide
(Lasix)
NCCEP Protocol: |
|
Definition
15-CHF Pulmonary Edema
50-Pediatric CHF Pulmonary
Edema |
|
|
Term
Furosemide
(Lasix)
Indications/Contraindications: |
|
Definition
Diuretic for pulmonary edema or
CHF but no proven benefit in
prehospital care |
|
|
Term
Furosemide
(Lasix)
Adult and Pediatric Dose |
|
Definition
See local protocol for dosing
guidelines |
|
|
Term
|
Definition
27-Diabetic; Adult
31-Overdose Toxic Ingestion
58-Pediatric Diabetic
60-Ped OD Toxic Ingestion |
|
|
Term
Glucagon
Indications/Contraindications: |
|
Definition
Drug acting to release glucose into
blood stream by glycogen
breakdown
Use in patients with no IV access |
|
|
Term
|
Definition
1 - 2 mg IM
Repeat blood glucose
measurement in 15 minutes, if ≤ 69
mg / dl repeat dose. |
|
|
Term
Glucagon
Pediatric Dosing |
|
Definition
See Color Coded List
0.1 mg/kg IM, Maximum 1 mg
Repeat blood glucose
measurement in 15 minutes, if ≤
69 mg / dl repeat dose. |
|
|
Term
Glucose Oral
Glucose Solutions
NCCEP Protocol: |
|
Definition
27-Diabetic; Adult
58-Pediatric Diabetic |
|
|
Term
Glucose Oral
Glucose Solutions
Indications/Contraindications: |
|
Definition
Use in conscious hypoglycemic
states |
|
|
Term
Glucose Oral
Glucose Solutions
Adult Dosing |
|
Definition
One tube or packet
Repeat based on blood glucose
results, per protocol |
|
|
Term
Glucose Oral
Glucose Solutions
Pediatric Dosing |
|
Definition
See Color Coded List
One Tube or packet
Repeat based on blood glucose
results, per protocol
Consider patient’s ability to
swallow and follow directions
based on age |
|
|
Term
Haloperidol
(Haldol)
Phenothiazine
Preperation
NCCEP Protocol: |
|
Definition
|
|
Term
Haloperidol
(Haldol)
Phenothiazine
Preperation
Indications/Contraindications: |
|
Definition
Medication to assist with sedation
of agitated patients |
|
|
Term
Haloperidol
(Haldol)
Phenothiazine
Preperation
Adult Only Dose
No pediatric use |
|
Definition
2.5-10 mg IV/IM, per local protocol
See local protocol for relative
contraindications and/or indications
to contact medical control for use
of this drug. |
|
|
Term
Ibuprofen
(Motrin)
Non-steroidal Antiinflammatory
Drug
NCCEP Protocol: |
|
Definition
7-Pain Control Adult
46-Pediatric Pain Control
72-Fever |
|
|
Term
Ibuprofen
(Motrin)
Non-steroidal Antiinflammatory
Drug
Indications/Contraindications: |
|
Definition
Avoid NSAIDS in women who are
pregnant or could be pregnant.
A nonsteroidal anti-inflammatory
drug (NSAID) used for pain and
fever control.
Not to be used in patients with
history of GI Bleeding (ulcers) or
renal insufficiency.
Not to be used in patients with
allergies to aspirin or other
NSAID drugs
Avoid in patients currently taking
anticoagulants, such as
coumadin. |
|
|
Term
Ibuprofen
(Motrin)
Non-steroidal Antiinflammatory
Drug
Adult Dosing |
|
Definition
|
|
Term
Ibuprofen
(Motrin)
Non-steroidal Antiinflammatory
Drug
Pediatric Dosing |
|
Definition
See Color Coded List
10 mg/kg po
Do not use in patients 6 months
of age or younger |
|
|
Term
Ipratropium
(Atrovent)
NCCEP Protocol: |
|
Definition
24-Allergic Reaction Anaphylaxis
26-COPD Asthma
56-Pediatic Allergic Reaction
61-Pediatric Respiratory Distress |
|
|
Term
Ipratropium
(Atrovent)
Indications/Contraindications: |
|
Definition
Medication used in addition to
albuterol to assist in patients with
asthma and COPD |
|
|
Term
Ipratropium
(Atrovent)
Adult Dosing |
|
Definition
2 puffs per dose of MDI (18
mcg/spray)
--- OR ---
0.5 mg per nebulizer treatment |
|
|
Term
Ipratropium
(Atrovent)
Pediatric Dosing |
|
Definition
Use in Pediatrics as a combined
Therapy with a Beta Agonist such
as Albuterol
2 puffs per dose of MDI (18
mcg/spray)
--- OR ---
0.5 mg per nebulizer treatment |
|
|
Term
Ketorolac
(Toradol)
Non-steroidal Antiinflammatory
Drug
NCCEP Protocol: |
|
Definition
7-Pain Control Adult
46-Pediatric Pain Control |
|
|
Term
Ketorolac
(Toradol)
Non-steroidal Antiinflammatory
Drug
Indications/Contraindications: |
|
Definition
Avoid NSAIDS in women who are
pregnant or could be pregnant
A nonsteroidal anti-inflammatory
drug used for pain control.
Not to be used in patients with
history of GI bleeding (ulcers),
renal insufficiency, or in patients
who may need immediate
surgical intervention (i.e. obvious
fractures).
Not to be used in patients with
allergies to aspirin or other
NSAID drugs such as motrin
Avoid in patients currently taking
anticoagulants such as coumadin |
|
|
Term
Ketorolac
(Toradol)
Non-steroidal Antiinflammatory
Drug
Adult Dosing |
|
Definition
| 30 mg IV / IO or 60 mg IM |
|
|
Term
Ketorolac
(Toradol)
Non-steroidal Antiinflammatory
Drug
Pediatric Dosing |
|
Definition
0.5 mg/kg IV / IO / IM
Maximum 30 mg |
|
|
Term
Lactated Ringer’s
Solution
NCCEP Protocol: |
|
Definition
40-Adult Thermal Burn
67-Pediatric Thermal Burn |
|
|
Term
Lactated Ringer’s
Solution
Indications/Contraindications: |
|
Definition
Crystalloid solution preferred for
fluid rescuscitation and preferred
in burn care. |
|
|
Term
Lactated Ringer’s
Solution
Adult and Pediatric |
|
Definition
Dosing per protocol, similar to
Normal Saline |
|
|
Term
|
Definition
4-Airway Rapid Sequence
Intubation
18-VF Pulseless VT
53-Pediatric VF Pulseless VT |
|
|
Term
Lidocaine
Indications/Contraindications: |
|
Definition
Antiarrhythmic used for
control of ventricular
dysrrythmias
Anesthetic used during intubation
to prevent elevated intracranial
pressures during intubation |
|
|
Term
|
Definition
1.5 mg/kg IV / IO bolus (ETT dose
= 2 x IV dose) up to 3mg/kg max
bolus dose
See local protocol for specific
dosing algorithm |
|
|
Term
Lidocaine
Pediatric Dosing |
|
Definition
See Color Coded List
1 mg/kg IV / IO
Maximum 100 mg
Repeat 0.5 mg/kg
Maximum 3 mg/kg total |
|
|
Term
Magnesium Sulfate
NCCEP Protocol: |
|
Definition
|
|
Term
Magnesium Sulfate
Indications/Contraindications: |
|
Definition
Elemental electrolyte used to treat
eclampsia during the third
trimester of pregnancy.
A smooth muscle relaxor used in
refractory respiratory distress
resistent to beta-agonists |
|
|
Term
Magnesium Sulfate
Adult Dosing Respiratory Distress |
|
Definition
2 g IV / IO over 10 minutes
Repeat dosing per local protocol |
|
|
Term
Magnesium Sulfate
Adult Dosing OB Seizure |
|
Definition
2 g IV / IO over 2-3 minutes
Dose may be repeated once, or as
per local protocol |
|
|
Term
Magnesium Sulfate
Pediatric Dosing |
|
Definition
40 mg/kg IV / IO over 20 minutes
(Max 2 gms)
Repeat dosing per local protocol |
|
|
Term
Methylprednisolone
(Solu-medrol)
Steroid Preparation
NCCEP Protocol: |
|
Definition
24-Allergic Reaction Anaphylaxis
26-COPD Asthma
56-Pediatic Allergic Reaction
61-Pediatric Respiratory Distress |
|
|
Term
Methylprednisolone
(Solu-medrol)
Steroid Preparation
Indications/Contraindications: |
|
Definition
Steroid used in respiratory distress
to reverse inflammatory and
allergic reactions |
|
|
Term
Methylprednisolone
(Solu-medrol)
Steroid Preparation
Adult Dosing |
|
Definition
125 mg IV / IO
IM dosing only if indicated by local
protocol |
|
|
Term
Methylprednisolone
(Solu-medrol)
Steroid Preparation
Pediatric Dosing |
|
Definition
See Color Coded List
2 mg/kg IV / IO (Max 125 mg)
IM dosing only if indicated by
local protocol |
|
|
Term
Midazolam
(Versed)
Benzodiazepine
NCCEP Protocol: |
|
Definition
|
|
Term
Midazolam
(Versed)
Benzodiazepine
Indications/Contraindications: |
|
Definition
Benzodiazepine used to control
seizures and sedation
Quick acting Benzodiazepine
Preferred over Valium for IM use
Use with caution if BP < 110 |
|
|
Term
Midazolam
(Versed)
Benzodiazepine
Adult Dosing |
|
Definition
See individual protocols for dosing
Usual total dose: 2.5-5 mg IV / IO /
IM |
|
|
Term
Midazolam
(Versed)
Benzodiazepine
Pediatric Dosing |
|
Definition
See Color Coded List
See individual protocols for
dosing
Usual total dose 0.1-0.2 mg/kg IV
/ IO / IM / IN |
|
|
Term
Morphine Sulfate
Narcotic Analgesic
NCCEP Protocol: |
|
Definition
|
|
Term
Morphine Sulfate
Narcotic Analgesic
Indications/Contraindications: |
|
Definition
Narcotic pain relief
Possible beneficial effect in
pulmonary edema
Avoid use if BP < 110 |
|
|
Term
Morphine Sulfate
Narcotic Analgesic
Adult Dosing |
|
Definition
4 mg IM/IV/IO bolus then 2 mg
IM/IV/IO every 5-10 minutes until a
maximum of 10 mg or clinical
improvement |
|
|
Term
Morphine Sulfate
Narcotic Analgesic
Pediatric Dosing |
|
Definition
See Color Coded List
0.1 mg/kg IV / IO / IM
May repeat every 5 minutes
Maximum single dose 5 mg
Maximum dose 10 mg |
|
|
Term
Naloxone
(Narcan)
Narcotic Antagonoist
NCCEP Protocol: |
|
Definition
31-Overdose Toxic Ingestion
60-Ped OD Toxic Ingestion |
|
|
Term
Naloxone
(Narcan)
Indications/Contraindications: |
|
Definition
|
|
Term
Naloxone
(Narcan)
Adult Dosing |
|
Definition
0.4 - 2 mg IV / IO / IM / IN / ETT
bolus titrated to patient’s
respiratory response |
|
|
Term
Naloxone
(Narcan)
Pediatric Dosing |
|
Definition
See Color Coded List
0.1 mg/kg IV / IO / IN / IM / ETT
(Max 2 mg)
Repeat as per protocol |
|
|
Term
Normal Saline
Crystalloid Solutions
NCCEP Protocol: |
|
Definition
|
|
Term
Normal Saline
Crystalloid Solutions
Indications/Contraindications: |
|
Definition
IV fluid for IV access or volume
infusion |
|
|
Term
Normal Saline
Crystalloid Solutions
Adult Dosing |
|
Definition
See individual protocol for bolus
dosing and/or infusion rate |
|
|
Term
Normal Saline
Crystalloid Solutions
Pediatric Dosing |
|
Definition
See Color Coded List
See individual protocol for bolus
dosing and/or infusion rate
Usual initial bolus 20 mL / kg IV /
IO |
|
|
Term
Nitroglycerin
NCCEP Protocol: |
|
Definition
14-Chest Pain and STEMI
15-CHF Pulmonary Edema |
|
|
Term
Nitroglycerin
Indications/Contraindications: |
|
Definition
Vasodilator used in anginal
syndromes and CHF. |
|
|
Term
Nitroglycerin
Adult Dosing
No Pediatric Use |
|
Definition
0.3 / 0.4 mg SL every 5 minutes
until painfree
See Chest Pain Protocol for paste
dosing |
|
|
Term
Nitrous Oxide
NCCEP Protocol: |
|
Definition
|
|
Term
Nitrous Oxide
Indications/Contraindications: |
|
Definition
Medication used to assist with
control of pain |
|
|
Term
Nitrous Oxide
Adult Dosing |
|
Definition
Inhaled gas to effect per local
protocol |
|
|
Term
Nitrous Oxide
Pediatric Dosing |
|
Definition
Inhaled gas to effect per local
protocol |
|
|
Term
Ondansetron
(Zofran)
Anti-emetic
NCCEP Protocol: |
|
Definition
23-Abdominal Pain Protocol
35-Vomiting and Diarrhea
63-Pediatric Vomiting and
Diarrhea |
|
|
Term
Ondansetron
(Zofran)
Anti-emetic
Indications/Contraindications |
|
Definition
Anti-Emetic used to control
Nausea and/or Vomiting
Ondansetron (Zofran) is the
recommended Anti-emetic for
EMS use since it is associated
with significantly less side effects
and sedation. |
|
|
Term
Ondansetron
(Zofran)
Anti-emetic
Adult Dosing |
|
Definition
4 mg IV / IO / IM / PO / ODT
Repeat only as per local protocol |
|
|
Term
Ondansetron
(Zofran)
Anti-emetic
Pediatric Dosing |
|
Definition
0.15 mg/kg IV / IO / IM
(Max 4 mg)
0.2 mg/kg PO / ODT (Max 4 mg)
Repeat only as per local protocol |
|
|
Term
|
Definition
|
|
Term
Oxygen
Indications/Contraindications |
|
Definition
Indicated in any condition with
increased cardiac work load,
respiratory distress, or illness or
injury resulting in altered
ventilation and/or perfusion.
Goal oxygen saturation 94-99%.
Indicated for pre-oxygenation
whenever possible prior to
endotracheal intubation. Goal
oxygen saturation 100%. |
|
|
Term
|
Definition
1-4 liters/min via nasal cannula
6-15 liters/min via NRB mask
15 liters via BVM / ETT / BIAD |
|
|
Term
|
Definition
1-4 liters/min via nasal cannula
6-15 liters/min via NRB mask
15 liters via BVM / ETT / BIAD |
|
|
Term
Oxymetazoline
(Afrin or Otrivin)
Nasal Decongestant
Spray
NCCEP Protocol: |
|
Definition
|
|
Term
Oxymetazoline
(Afrin or Otrivin)
Nasal Decongestant
Spray
Indications/Contraindications |
|
Definition
Vasoconstrictor used with nasal
intubation and epistaxis
Relative Contraindication is
significant hypertension |
|
|
Term
Oxymetazoline
(Afrin or Otrivin)
Nasal Decongestant
Spray
Adult Dosing |
|
Definition
2 sprays in affected nostril
Usual concentration is 0.05% by
volume |
|
|
Term
Oxymetazoline
(Afrin or Otrivin)
Nasal Decongestant
Spray
Pediatric Dosing |
|
Definition
See Color Coded List
1-2 sprays in affected nostril
Usual concentration is 0.05% by
volume |
|
|
Term
Pralidoxime
(2-PAM)
NCCEP Protocol: |
|
Definition
|
|
Term
Pralidoxime
(2-PAM)
Indications/Contraindications |
|
Definition
Antidote for Nerve Agents or
Organophosphate Overdose
Administered with Atropine |
|
|
Term
Pralidoxime
(2-PAM)
Adult Dosing |
|
Definition
600 mg IV / IO / IM over 30
minutes for minor symptoms
1800 mg IV / IO / IM over 30
minutes for major symptoms
See local protocol for minor versus
major indications |
|
|
Term
Pralidoxime
(2-PAM)
Pediatirc Dosing |
|
Definition
15 – 25 mg/kg IV / IM / IO over
30 minutes
See local protocol for specific
pediatric dosing
recommendations |
|
|
Term
Promethazine
(Phenergan)
Anti-emetic
NCCEP Protocol: |
|
Definition
23-Abdominal Pain
35-Vomiting and Diarrhea |
|
|
Term
Promethazine
(Phenergan)
Anti-emetic
Indications/Contraindications |
|
Definition
IV Promethazine (Phenergan)
should be given IV only with great
caution. Extravasation of this
drug can result in significant local
tissue damage.
Anti-Emetic used to control
Nausea and/or Vomiting
Ondansetron (Zofran) is the
recommended Anti-emetic for
EMS use since it is associated
with significantly less side effects
and sedation. |
|
|
Term
Promethazine
(Phenergan)
Anti-emetic
Adult Only Dosing |
|
Definition
12.5 mg IV / IO / IM
May repeat as per local protocol |
|
|
Term
Rocuronium
NCCEP Protocol: |
|
Definition
|
|
Term
Rocuronium
Indications/Contraindications |
|
Definition
Non-depolarizing paralytic agent
used as a component of drug
assisted intubation (Rapid
Sequence Intubation), when
succinylcholine is
contraindicated.
Onset of action is longer than
succinylcholine, up to 3 minutes,
patient will NOT defasciculate. |
|
|
Term
Rocuronium
Adult Only Dosing |
|
Definition
1 mg / kg IV / IO
Only may repeat x1 per RSI
protocol |
|
|
Term
Sodium Bicarbonate
NCCEP Protocol: |
|
Definition
28-Dialysis Renal Failure
31-Overdose Toxic Ingestion
60-Ped OD Toxic Ingestion
88-Crush Syndrome |
|
|
Term
Sodium Bicarbonate
Indications/Contraindications |
|
Definition
A buffer used in acidosis to
increase the pH in Cardiac
Arrest, Hyperkalemia or Tricyclic
Overdose. |
|
|
Term
Sodium Bicarbonate
Adult Dosing |
|
Definition
Initial bolus 50 mEq IV / IO
See individual protocol for specific
dosing algorithm |
|
|
Term
Sodium Bicarbonate
Pediatric Dosing |
|
Definition
See Color Coded List
Initial bolus 1 mEq / kg IV / IO
Maximum 50 mEq
See individual protocol for
specific dosing algorithm |
|
|
Term
Succinylcholine
Paralytic Agent
NCCEP Protocol: |
|
Definition
4-Airway Rapid Sequence
Intubation |
|
|
Term
Succinylcholine
Paralytic Agent
Indications/Contraindications |
|
Definition
Paralytic Agent used as a
component of Drug Assisted
Intubation (Rapid Sequence
Intubation)
Avoid in patients with burns >24
hours old, chronic neuromuscular
disease (e.g., muscular
dystrophy), ESRD, or other
situation in which hyperkalemia is
likely. |
|
|
Term
Succinylcholine
Paralytic Agent
Adult Only Dosing |
|
Definition
1.5 mg/kg IV / IO
Only may repeat x1 per RSI
protocol |
|
|
Term
Vasopressin
(Pitressin)
NCCEP Protocol: |
|
Definition
11-Asystole Pulseless Electrical
Activity
18-VF Pulseless VT |
|
|
Term
Vasopressin
(Pitressin)
Indications/Contraindications |
|
Definition
Medication used in place of and/or
in addition to epinephrine in the
setting of cardiac arrest |
|
|
Term
Vasopressin
(Pitressin)
Adult Only Dosing |
|
Definition
40 units IV / IO, may replace first or
second dose of epinephrine |
|
|
Term
Vecuronium
Paralytic Agent
NCCEP Protocol: |
|
Definition
4-Airway Rapid Sequence
Intubation
19-Post Resuscitation
20-Induced Hypothermia |
|
|
Term
Vecuronium
Paralytic Agent
Indications/Contraindications |
|
Definition
Long-acting non-depolarizing
paralytic agent
Avoid in patients with chronic
neuromuscular disease (e.g.,
muscular dystrophy). |
|
|
Term
Vecuronium
Paralytic Agent
Adult Only Dosing |
|
Definition
|
|
